Siemens Logo
Siemens References
record image
Stepping up the pace in vaccine development and production
GSK is collaborating with Siemens and ATOS to optimize vaccine development and production

Pharmaceuticals

GlaxoSmithKline (GSK)

Greenford, Middlesex United Kingdom

Wavre, Belgium
Wavre,
Belgium
Award Winner
Developing vaccines is usually a costly and time-consuming process. It can take up to several years.   
Right now, vaccine development typically progresses in many small silos, each digitalized to some extent in its own environment, but with few connections between them. Often one group depends on the completion of the work by another team to be able to access data. This is where there is potential for optimization.
Digital Enterprise solution from Siemens :
  • SIPAT process analysis technology   
  • Totally Integrated Automation Portal (TIA Portal)   
  • AI and ATOS software structure

  • Significant improvement of the entire value chain through integration and digitalization
  • Easier and earlier access to results 
  • Faster and more comprehensive feedback 
  • Better ability to predict and share outcomes 
  • Providing better oversight of the entire process  
  • Faster vaccine development with best information available during production using the digital twin
  • Advantages of the Digital Twin:
    • Testing stages in the process
    • Gaining insights in a virtual environment right at the outset
    • Predicting the performance of the process
    • Anticipating deviation and steering the control back to the optimal production
    • Ensuring reliable supply through feeding back the data obtained from real runs with machine learning 
    • Using obtained data to optimize the digital twin, the products and processes from an early stage
Every day, GSK manufactures around two million vaccine doses, making it one of the world’s largest suppliers. Now GSK is turning to digitalization to help speed things up: collaborating with Siemens, it aims to create and introduce digital twins of the entire vaccine manufacturing process for all new vaccines. In other words, the digital twins of the product, production, and performance will be linked together.
Awards
Werner-von-Siemens Award Customer First 2020
Related Links
Please note that some of the links may be only available in Intranet.
Contact
Contact our sales for more information and to discuss directly how our products and solutions could help you to best solve your problem.
Contact Sales
Recommended Contributions

Completion 2021

Fast track COVID-19 production in Marburg

Release Year 2021

“We give the user a valuable time advantage “

BioNTech - Digitized production for personalized medicine

ID: 23772